Answered You can buy a ready-made answer or pick a professional tutor to order an original one.
essay
Let's talk about the case you just completed--the Pfizer case. Questions I'm interested in discussing are:
**************
--Why has the pharmaceutical industry been so successful historically?
--What is your assessment of the pharmaceutical industry at the time of the case? How is competition changing? What factors are driving the changes?
--What will competition in pharmaceuticals look like in 10 years?
--What is your assessment of Pfizer’s position in the industry? What are the keys to success in the industry?
--What recommendations would you make to Kindler?
***************
I don't expect you to answer all these questions. Pick a couple and offer your thoughts and ideas. I realize you probably answered all these questions in your case analysis, but don't cut and paste from your paper or post your entire paper :-) Rather, offer brief highlights and thoughts in your own words. What I'm really looking for is your discussion with each other. I want you to read other answers and offer your opinions on a few of them.
(500-600 words, 3 citations)
- @
- 331 orders completed
- ANSWER
-
Tutor has posted answer for $50.00. See answer's preview
************** ******** *******
10
***** report ******
rate
** ******
- @
- 1767 orders completed
- ANSWER
-
Tutor has posted answer for $10.00. See answer's preview
*** ************** industry *** **** ** ********** ************ ******* *** industry has ***** * *** ** **** ** the ******** *** the drugs **** *** ******** for *** treatment ** ******* ******** ******* **** *************** *** produce the drugs that *** ******** *** the ********* ** ******* ************ **** **** **** ** ********** ******* **** **** **** *** generic ** ***** medication *** ******* ************** **** *** ******* ******* ** ******* *********** **** ****** the ********************** efficacy *** ********* ** ******
**
*** **** ** the **** *** pfizers ******** *** ***** ********** *** there *** *********** **** still existed ******** the ******** *** ***** leading ** *** ******** ******* of *** continued research **** ** ** why **** of *** businesses **** ** ** merged *** *** company *** *** ***** *** acquiring ***** manufacturers *** ********* ******* *** products **** ***** **** *** **** ***** **** for treatment ** ******* diseasesFrom **** **** the competition *** continued ** ****** ***** ************ have **** into the market *** thereby **** *** ******** *** market *** ******** **** *** ******** ******** hence *** ******** are not ********* ** **** ***** ******* **** ** *** ******** that **** get from the ****** **** feel *** ****** for ***** healthThe competition ** continuing to ****** ******* *** pharmaceutical ******** is changing *** *** traditional ***** ** ********** *** ** longer ******** * ************ ********* ************* climate *** growing interest ** ******** ***** has ****** *** ***** **** ************ ** ***** medicines *** *** ********* ***** ** emerging ******* *** have ******** *** **** structure *** ************* of **** ************* ***** ** in **** ********* ******* needs and ************ ********** pharmaceutical companies **** ** some ****** ********* ********** networks ********* varying ******** groups **** insurance ********* to *** ******** ******* centers in ***** ** support *** ********* development *** ***************** ** *** ********** The
pharmaceutical
******** *** got * complex ******** to **** ** *** pricing of *** ******* ******** **** the person ****** *** ***** ** *** one *** will ******* *** *** to pay *** **** For *** **** ** *** patients *** **** ** consuming *** ********** ***** is shared **** *** insurance ***** ******* *** ******** *** ******** ******* ******** *** ********* *** **** ****** due to *** ********** **** **** ****** ***** ******* ** this ** ***** ** ******** *** *********** *** ** going ** widen **** *** future ***** ** * **** ** ***** pricing *********** ***** **** ** *** brands ****** **** vary *** this **** ** ***** *** ******** ** **** the ******** ** ***** *** which *** will ***** **** *** **** ** ******** ** ****** ** * ****** rate ** ************ ********* **
******
** an industry **** ** performing well ** *** ************** ****** *** **** *** been ******* it backwards are **** ** *** *********** that have **** ** place ***** *** ******* was *** ********* *** *********** *** *** ****** ****** *** it has ********* to ** well The key success ******* *** the ******** that *** ******* has ********* to ***** *** *** ********** and also ****** ************ **** have **** *** ******* ** ** *********** ***** *** *******
recommendations
that ******* could get ** ***** ******* trying to ********* **** *** safety and health sector ** ***** ******** ** ******** *** *** ******* ** the ***** to ** carried *** **** **** ***** ****** also be ****** regulations **** *** ** ******** so as ** ****** ***** ** no **** of *** *** **** ** broken in *** way and ******* *** regulations should be favorable ***** *** business ****** be ** an **** ***** the **** ***** *** Sources * C Monteiro
and
*
B
A ****** *** ******* Contam ******* **** *** ** *** G **** *** J ***** ********** **
the
***************** Pipeline: A **************** View ******** ***** ****** 2013 Anon accessed ** ********* **** ****************************************************************************************************************************************